Substituted Pyridine Compounds for AMPK Pathway Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for metabolic disorders such as type II diabetes, atherosclerosis, and cardiovascular disease do not effectively activate the AMPK pathway, which is crucial for regulating cellular energy homeostasis and improving insulin sensitivity.
Innovation Solution
Development of specific substituted pyridine compounds, including N-((cis)-1-(4-cyanobenzyl)-3-fluoropiperidin-4-yl)-6-(4-(4-methoxybenzoyl)piperidine-1-carbonyl)nicotinamide, and their pharmaceutical compositions that activate the AMPK pathway by binding to the adiponectin receptor, mimicking adiponectin's action to increase glucose uptake, fatty acid oxidation, and reduce glycogen and triglyceride levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for metabolic disorders are used, then disease management is maintained, but AMPK pathway activation is insufficient
Solution Approach 1:
The patent changes the chemical structure parameters by introducing specific substituents at defined positions on the pyridine ring (positions 3 and 5), and by modifying the R1-R6 groups according to formula (I). These parameter changes in molecular structure result in enhanced AMPK pathway activation capability, directly resolving the contradiction between maintaining treatment feasibility and improving pathway activation reliability.
2Reliability
If AMPK pathway is activated, then insulin sensitivity is improved, but treatment complexity increases
Solution Approach 1:
The patent applies local quality by introducing specific functional groups at particular positions (R1-R6 substituents) on the pyridine core structure. Each substituent position is optimized independently to contribute specific properties: some positions enhance AMPK binding affinity, others improve metabolic stability, and others enhance insulin sensitivity. This localized optimization allows the complex molecule to achieve reliable therapeutic effects through distributed functional elements rather than uniform complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively activate the AMPK pathway, enhancing insulin sensitivity, reducing triglyceride and glycogen levels, and inhibiting inflammatory processes associated with atherosclerosis, thereby treating or preventing type II diabetes and cardiovascular diseases.
Implementation Method 1
activate the AMPK pathway by binding to the adiponectin receptor, mimicking adiponectin's action
Implementation Method 2
Activation of the AMPK pathway improves insulin sensitivity by directly stimulating glucose uptake in adipocytes and muscle
Implementation Method 3
Activation of the AMPK pathway improves insulin sensitivity by directly stimulating glucose uptake in adipocytes and muscle and by increasing fatty acid oxidation in liver and muscle
Implementation Method 4
Activation of the AMPK pathway also decreases glycogen concentration by reducing the activity of glycogen synthase
Implementation Method 5
Activation of the AMPK pathway also plays a protective role against inflammation and atherosclerosis. It suppresses the expression of adhesion molecules in vascular endothelial cells and cytokine production from macrophages
Data Source
AI summary
Disclosed are substituted pyridine compounds as well as pharmaceutical compositions and methods of use. One embodiment is a compound having the structure wherein E, J, T, the ring system denoted by "B", T, R3, R4, w and x are as described herein. In certain embodiments, a compound disclosed herein activates the AMPK pathway, and can be used to treat metabolism-related disorders and conditions.